Pre-earnings options volume in Sellas Life Sciences (SLS) is 1.5x normal with calls leading puts 430:1. Implied volatility suggests the market is anticipating a move near 22.6%, or 0c, after results are released. Median move over the past eight quarters is 5.5%.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter